CAS NO: | 832720-36-2 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 |
Elagolix sodium is a humanGnRH receptor(GnRHR) antagonist with anIC50andKiof 0.25 and 3.7 nM, respectively. |
||||||||||||||||
IC50& Target |
IC50: 0.25 nM (GnRHR)[1] |
||||||||||||||||
体外研究 (In Vitro) |
Elagolix sodium is a human GnRH receptor (GnRHR) antagonist with an IC50of 0.25 nM in Kinase assay. Elagolix sodium has advanced to phase 3 trials for the treatment of endometriosis and uterine fibroids. Elagolix sodium also shows NFAT inhibition with an IC50of 5.4 nM and effectively blocks Ca2+flux with an IC50of 0.86 nM[1]. Kinase assay also demonstrates that Elagolix sodium is a human GnRH receptor (GnRHR) antagonist with a Kivalue of 3.7 nM[2].
|
||||||||||||||||
Clinical Trial |
|
||||||||||||||||
分子量 |
653.57 |
||||||||||||||||
性状 |
Solid |
||||||||||||||||
Formula |
C32H29F5N3NaO5 |
||||||||||||||||
CAS 号 |
832720-36-2 |
||||||||||||||||
中文名称 |
恶拉戈利钠杂质27 |
||||||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||
储存方式 |
4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : 50 mg/mL(76.50 mM;Need ultrasonic) H2O : ≥ 50 mg/mL(76.50 mM) *"≥" means soluble, but saturation unknown.
配制储备液
*
请根据半岛bd体育手机客户端 在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的半岛bd体育手机客户端 失效。
In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
*
以上所有助溶剂都可在本网站选购。
|